Innogen · Publications · Briefings
Sustainable (Vaccine) Development: The International AIDS Vaccine Initiative (IAVI) and Capacity Building
Product Development Partnerships (PDPs), of which the International AIDS Vaccine Initiative (IAVI) is one, are being developed to try and bridge the gap between scientific and technological potential and the needs of the poor in developing countries. Consequently, PDPs are now the recipients of large amounts of development donor funds. Although the primary concern of many involved in PDPs is to generate products to address neglected diseases and illnesses which affect people in developing countries, donors are also keen that initiatives work with partners in the global South and increase scientific and technological related capacities in the South. This has implications for the way PDPs are assessed and performance is measured.
Based on case study fieldwork of IAVI carried out over the last four years, we argue that PDPs can provide a means of moving forward sustainable development objectives, highlighting the importance of what we term ocial technology the transfer, and creation, of institutional capacity particularly local ownership of vaccine development resulting from advocacy activities.